Ovation Science Inc.
OVATF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 82.8% | -55.2% | -38.6% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 75.7% | 87.4% | 97.8% | 83.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $1 |
| SG&A Expenses | $0 | $0 | $0 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $1 | $1 | $1 | $1 |
| Operating Income | -$0 | -$1 | -$1 | -$2 |
| % Margin | -423.1% | -1,122.4% | -534.7% | -674.1% |
| Other Income/Exp. Net | $0 | -$0 | -$0 | -$1 |
| Pre-Tax Income | -$0 | -$1 | -$1 | -$2 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$0 | -$1 | -$1 | -$2 |
| % Margin | -402.9% | -1,312.9% | -574.8% | -1,064.1% |
| EPS | -0.013 | -0.027 | -0.027 | -0.082 |
| % Growth | 51.5% | 0.7% | 66.9% | – |
| EPS Diluted | -0.013 | -0.027 | -0.027 | -0.082 |
| Weighted Avg Shares Out | 35 | 30 | 29 | 29 |
| Weighted Avg Shares Out Dil | 35 | 30 | 29 | 29 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$1 | -$1 | -$2 |
| % Margin | -357% | -1,257.5% | -569.5% | -674.1% |